Drug Information

Drug General Information
Drug ID
D0Q4YP
Former ID
DCL000648
Drug Name
TAK-100
Drug Type
Small molecular drug
Indication Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] Discontinued in Phase 1 [548755]
Company
Takeda
Formula
C22H32N2O3
Canonical SMILES
CCC1=NC(=C(C(=C1CC(=O)O)C2=CC=C(C=C2)C)CN)CC(C)(C)C.O
InChI
1S/C22H30N2O2.H2O/c1-6-18-16(11-20(25)26)21(15-9-7-14(2)8-10-15)17(13-23)19(24-18)12-22(3,4)5;/h7-10H,6,11-13,23H2,1-5H3,(H,25,26);1H2
InChIKey
AHWOGMYVGNUCOU-UHFFFAOYSA-N
PubChem Compound ID
53326686
PubChem Substance ID
124976189
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Inhibitor [551717]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 548755Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028364)
Ref 551717Clinical pipeline report, company report or official report of Takeda (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.